Format

Send to

Choose Destination
Rheumatology (Oxford). 2014 Jul;53(7):1219-28. doi: 10.1093/rheumatology/ket481. Epub 2014 Mar 4.

Identification of novel autoantibodies to GABA(B) receptors in patients with neuropsychiatric systemic lupus erythematosus.

Author information

1
Division of Rheumatic Diseases, National Center for Global Health and Medicine and Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.Division of Rheumatic Diseases, National Center for Global Health and Medicine and Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan. elephantscale@yahoo.co.jp.
2
Division of Rheumatic Diseases, National Center for Global Health and Medicine and Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.

Abstract

OBJECTIVE:

The gamma-aminobutyric acid type B receptors (GABAR(B)) are G-protein coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. We identified GABAR(B) subunits as candidate antigens in patients with SLE using a random peptide display library. The aim of this study was to investigate the possible link between anti-GABAR(B) antibodies and disease activity and NPSLE.

METHODS:

ELISA was performed with recombinant proteins of GABAR(B1b) and GABAR(B2) on serum samples from patients with SLE (n = 88), scleroderma (n = 20), myositis (n = 20) or vasculitis (n = 20) as well as healthy subjects (n = 20). Cerebrospinal fluid (CSF) from 23 patients with SLE was also examined.

RESULTS:

Autoantibodies to GABAR(Bs) were exclusive to patients with SLE (P < 0.001) and positively associated with SLEDAI (anti-GABAR(B1b), P = 0.001; anti-GABAR(B2), P < 0.001). Of note, autoantibodies were positively linked with NPSLE (anti-GABAR(B1b), P = 0.02; anti-GABAR(B2), P = 0.03). Moreover, anti-GABAR(Bs) was detected in 61.5% of CSF samples from patients with active NPSLE, a frequency that was significantly higher than that for patients with non-SLE syndromes.

CONCLUSION:

Anti-GABAR(B) antibodies could represent novel candidate markers for disease activity and NPSLE.

KEYWORDS:

GABAB receptor; autoantibody; disease activity; neuropsychiatric systemic lupus erythematosus; systemic lupus erythematosus

PMID:
24599914
DOI:
10.1093/rheumatology/ket481
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center